DOC ASX Week ended 07 Aug 2026

Weekly Investor Report

Doctor Care Anywhere Group PLC · Healthcare · Health Information Services

Latest close 0.10 AUD
-4.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -24.3% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -4.5%, after a -14.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 19 out of 100
Latest Close 0.10 AUD 7 Aug 2026
1W Return -4.5% latest completed week
4W Return -14.3% short-term follow-through
12W Return -25.0% quarterly tape
Trend Breadth 36.5% 19 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 41.32% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -24.3% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -4.5%, after a -14.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2012-week average 0.37

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.20Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -14.3% over four weeks, -25.0% over 12 weeks, and -27.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.5%
4W-14.3%
12W-25.0%
26W-30.0%
52W-27.6%
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.29Latest activity-pressure read.
Pressure change-25.6%Four-week change in activity pressure.
Leadership-30.19Latest relative-leadership reading.
RS change-96.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 76% Model confidence 60%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value13/100Relative valuation strength. Underlying universe rank 88; rank 1 is best.
Quality88/100Profitability and accounting quality. Underlying universe rank 13; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
33.3x
Price divided by trailing earnings.
Price / sales
1.0x
Market value relative to trailing revenue.
EV / EBITDA
9.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
43.2%
Gross profit retained from each unit of revenue.
Operating margin
-2.0%
Operating profit retained from revenue.
Free-cash-flow margin
6.8%
Free cash flow generated from revenue.
Return on invested capital
-15.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-3.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 10 relevant articles.

0 positive · 10 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-50.0%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2612 weeks finished lower.
Best week+11.1%Week of 17 Apr.
Worst week-24.3%Week of 6 Mar.
Latest week-4.5%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains3
Flat weeks6
Modest losses4
Sharp losses8
Recent vol4.6%13-week weekly-return volatility.
Base vol7.7%52-week weekly-return volatility.
Up/down split17/24Count of positive and negative weeks in the 52-week window.
Average skew8.1% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20260.10 AUD-4.5%0.14 AUD0.10 AUD-1.29-30.19302.5KOff
31 Jul 20260.11 AUD-4.3%0.14 AUD0.10 AUD-1.13-24.98177.2KOff
24 Jul 20260.12 AUD-4.2%0.14 AUD0.10 AUD-1.08-20.0677.6KOff
17 Jul 20260.12 AUD-2.0%0.14 AUD0.10 AUD-1.01-16.9460.4KOff
10 Jul 20260.12 AUD2.1%0.14 AUD0.10 AUD-1.03-15.36938.8KOff
3 Jul 20260.12 AUD-4.0%0.14 AUD0.09 AUD-1.20-17.40304.4KOff
26 Jun 20260.12 AUD0.0%0.14 AUD0.09 AUD-1.11-13.1516.1KOff
19 Jun 20260.12 AUD4.2%0.14 AUD0.09 AUD-1.07-13.59210.6KOff
12 Jun 20260.12 AUD-11.1%0.14 AUD0.09 AUD-0.95-16.5291.8KOff
5 Jun 20260.14 AUD0.0%0.14 AUD0.09 AUD-0.71-3.921.3MOff
29 May 20260.14 AUD-6.9%0.14 AUD0.09 AUD-0.57-4.8520.8KOff
22 May 20260.14 AUD3.6%0.14 AUD0.09 AUD-0.293.45338.1KOn
15 May 20260.14 AUD-9.7%0.14 AUD0.09 AUD-0.280.761.1MOn
8 May 20260.15 AUD-3.1%0.14 AUD0.09 AUD-0.2710.69435.2KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context